Almac Group
Almac is a pharmaceutical service provider with over 30 years experience. The company provides a range of services including research and development, pharmaceutical testing and clinical trials as well as the commercialisation of pharmaceutical products. The company has experience in biomarker discovery and development through its partners and through internal R&D.
Almac provides comprehensive support from drug discovery through to scale-up and launch of new drugs. Pharmaceutical development includes pre-formulation of drugs, testing and taking them to market. The company has three chemical trial sites globally, with one in Northern Ireland situated at Craigavon.
The company also specialises in the design and manufacture of drug packaging including blistering, bottling and walleting/carding of pharmaceuticals.
Financial Data
-
30th Sep 17 Source: CRO
- €674.9 million turnover
-
€41.9 million
profit - 4,407 employees
-
30th Sep 16 Source: CRO
- €507.1 million turnover
-
€30.4 million
profit - 3,975 employees
- 9 more years available »
Ranking
By Turnover
(€674.9 million)- 114th in Top Companies
- 16th in Health
By Employees
(4,407)- 49th in Top Companies
- 8th in Health
-
- 4,407
- €674.9 million
Employees
- Alan Armstrong CEO/Managing Director
Latest News
- 6:12pm Apple warns Trump tariffs would hurt its competitiveness
- 6:06pm Markets hit six-week highs on rates and trade talks optimism
- 5:23pm Coillte to convert nine forests in Dublin Mountains to recreational use
- 4:00pm EU agrees multi-million aid package for Irish beef farmers
- 3:48pm Ten cities ask EU for help to fight Airbnb expansion